XXII is down -38.89% during regular trading to roughly $1.43, extending an after-hours slide that began after Wednesday's +29% surge to a $2.34 close. The move is driven by a report that the FDA and administration plan to fast-track authorization for newer tobacco products such as flavored vapes, threatening 22nd Century's status as the only FDA-authorized reduced-nicotine cigarette maker (VLN).
TPB fell -9.64% to about $61.57 during regular trading on Sept. 21, 2026, versus the prior close of $68.14. The drop followed the morning announcement that CEO Graham Purdy is stepping down Oct. 1 for personal reasons, with Executive Chairman David Glazek named as his successor.
Turning Point Brands recently traded near $75, placing the $100 target roughly 33% above current levels — a meaningful but not unrealistic gap. The $100 mark is a natural psychological milestone, and TPB traded well above it as recently as early 2026, peaking near $147 in February.
MO plunged -8.34% during regular trading after reporting Q2 2026 results that missed profit estimates, with the selloff accelerating sharply from a -3% premarket decline. Adjusted EPS came in at $1.48, missing the $1.50 consensus, as macroeconomic pressure drove smokers toward cheaper alternatives, eroding premium-brand demand.
Philip Morris International reported Q2 2026 net revenues exceeding $11 billion for the first time, reflecting close to 8% organic growth. Adjusted diluted earnings per share rose 15% in dollar terms and 14% on a currency-neutral basis.
Philip Morris International Inc. is a leading international tobacco company focused on manufacturing and selling cigarettes and other nicotine-containing products outside the United States. Its core business model centers on combustibles such as PM brands like Marlboro and Parliament, while rapidly expanding into smoke-free alternatives including heated tobacco systems like IQOS and nicotine pouches such as ZYN. The company operates primarily in the global tobacco industry, holding a strong competitive position through premium branding, extensive distribution networks, and innovation in reduced-risk products. These fundamentals, particularly the growing contribution from smoke-free businesses which accounted for a rising share of revenues, help explain the recent positive stock behavior as investors reward progress toward a diversified, lower-risk portfolio.
Altria Group (MO) stock rose approximately +13% over the past 30 days, driven primarily by a strong Q1 2026 earnings beat that propelled shares sharply higher at month-end. Over the past quarter, shares gained around +16%, reflecting recovery from earlier lows amid consistent operational performance and a shift toward smokefree products.
Analysts expect Q1 2026 adjusted EPS of $1.24, a slight increase from $1.23 in the year-ago quarter. Consensus revenue estimate stands at $4.56 billion, reflecting 0.9% year-over-year growth.
Philip Morris International Inc. (
PM) stands as a leading global tobacco company, focused on manufacturing and selling cigarettes, smoke-free products such as heated tobacco and nicotine pouches, and emerging alternatives. The core of its business model revolves around transitioning adult smokers to reduced-risk products, with smoke-free offerings like IQOS and Zyn generating 41.5% of total net revenues exceeding $40 billion in 2025. Operating in over 180 markets, PM maintains a strong competitive position in the tobacco industry against peers like British American Tobacco (
BTI), thanks to its scale, innovation in smoke-free technologies, and robust dividend yield. These fundamentals provide resilience, but regulatory hurdles in key markets like the U.S. and India have driven recent stock price volatility, as investors balance transition progress against approval risks.
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Smoke-free products accounted for 41.5% of total net revenues in 2025, with shipment volumes rising 12.8%.
An AI-driven comparison of Philip Morris (PM) and British American Tobacco (BTI) points to Philip Morris as the more attractive investment for 2026. The analysis highlights PM’s accelerated transition toward smoke-free products, which positions the company for sustainable growth as global regulations continue to pressure traditional combustible tobacco.
Join us as we dissect the Tobacco sector's impressive 17.55% monthly gain, led by $PM, $MO, $BTI, $VGR, and $UVV. Uncover the key factors fueling this remarkable growth in our latest market analysis.
The Tobacco industry has demonstrated a remarkable upswing in its performance over the past week, with a significant increase of +4.31%. This positive momentum is reflected across a group of prominent tickers within the industry, including XXII, GNLN, RLX, KAVL, and HPCO.
The RSI Indicator for PM moved out of oversold territory on March 27, 2023, which could be a positive sign for investors. This shift may indicate that the stock is moving from a downward trend to an upward trend, making it an attractive buy for traders looking to invest.
The volume for Turning Point Brands stock increased for one day, resulting in a record-breaking daily growth of 206% of the 65-Day Volume Moving Average
Altria reported third quarter earnings that were below analysts’ expectations. The tobacco company’s adjusted earnings came in at $1.28 per share in the quarter vs. $1.30 expected by analysts polled by Refinitiv. Revenue in the quarter was $5.41 billion, missing analysts’ expectations of $5.59 billion. Looking ahead, Altria narrowed its adjusted earnings per share outlook to a range of $4.81...
Shares of Greenlane Holdings was reinstated outperform rating by analysts at Cowen. Cowen analysts now have a price target of $5 a share. The analysts are bullish after Greenlane closed its merger with KushCo. on Sept. 1. "Combined, the company will be a clear leader in the ancillary cannabis space where distinct customer bases should provide a platform for cross-selling opportunities and...
The reasoning behind that belief is based on how demand for the products is pretty consistent and may even increase during stressful economic times.
While browsing through charts recently I found two sin stocks that can’t seem to break out of the downward trends they have been in for the last four years or so.Altria (MO) and Molson Coors Brewing (TAP) have both seen their stocks trend lower in recent years, but the companies have decent fundamental indicators.
If we look at the weekly chart for Altria we see that the stock has been trending lower since the second quarter of 2017 and from its peak through its low, the stock lost over half of its value.